Vicore Pharma Holding AB (VICO) Stock Statistics & Valuation Metrics

Vicore Pharma Holding AB has a market cap or net worth of €1.78B. The enterprise value is kr669.65M.

Vicore Pharma Holding AB has 234,579,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vicore Pharma Holding AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Vicore Pharma Holding AB is 0.00. Vicore Pharma Holding AB’s PEG ratio is 0.00.

In the last 12 months, Vicore Pharma Holding AB had revenue of 109.35M and earned -168.63M in profits. Earnings per share was -1.51.

In the last 12 months, operating cash flow was -164.95M and capital expenditures 49.56M, giving a free cash flow of -164.95M billion.

Vicore Pharma Holding AB pays an annual dividend of kr3.223, resulting in a dividend yield of ―

Vicore Pharma Holding AB upcoming earnings date is May 6, 2025, TBA Not Confirmed.

Vicore Pharma Holding AB as a current ratio of 16.50, with Debt / Equity ratio of 0.00%

In the past 12 months, Vicore Pharma Holding AB has paid -256.00K in taxes.

Vicore Pharma Holding AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Vicore Pharma Holding AB has €1.16B in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€1.16B billion.

Gross margin is 98.72%, with operating margin of -177.59%, and net profit margin of -154.22%.

The average price target for Vicore Pharma Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―